Safety of checkpoint inhibitors for cancer treatment: strategies for patient monitoring and management of immune-mediated adverse events
Marianne Davies,1–3 Emily A Duffield3 1Yale School of Nursing, 2Department of Medical Oncology, Yale Comprehensive Cancer Center, 3Department of Nursing, Smilow Cancer Hospital at Yale-New Haven Hospital, New Haven, CT, USA Abstract: Immune checkpoint inhibitors (ICPIs), in the form of mo...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2017-08-01
|
| Col·lecció: | ImmunoTargets and Therapy |
| Matèries: | |
| Accés en línia: | https://www.dovepress.com/safety-of-checkpoint-inhibitors-for-cancer-treatment-strategies-for-pa-peer-reviewed-article-ITT |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|